Table 1 Number of samples in each class in discovery and validation cohorts
From: Probabilistic modeling methods for cell-free DNA methylation based cancer classification
Class | Discovery cohort | Validation cohort |
|---|---|---|
Healthy controls (normal) | 24 | 62 |
Renal cancer (RCC) | 20 | – |
Pancreatic ductal adenocarcinoma (PDAC) | 24 | 47 |
Colorectal cancer (CRC) | 23 | – |
Bladder cancer (BLCA) | 20 | – |
Breast cancer (BRCA) | 25 | – |
Lung cancer (LUC) | 25 | 55 |
Acute myeloid leukemia (AML) | 28 | 35 |
Total | 189 | 199 |